Begin typing your search above and press return to search.
Please, set Additional Menu

About

Our Mission & Vision

Build-up a ‘First-/Best -in-Class’ Innovative Portfolio in Human Metabolic and Neurodegenerative Diseases

ABAXYS Therapeutics aims to become a key player and first-choice partner in the area of human severe diseases. We want to contribute to the development of highly innovative therapeutic solutions for metabolic and neurodegenerative diseases

Our approach will significantly reduce the time-to-clinics of efficacious disease modifying therapies

Our Key Approach

Our strategy is based on a business model which uses the local and European top R&D ecosystem to deliver disruptive Preclinical packages contributing to High Value Pharma Therapeutic programs

1
Hit Identification

With our Data Mining approach, we are able to efficiently identify new Hits.

2
Lead Optimization

With our Big Data and Simulation approach, we are able to accelerate the Preclinical process (from 3-5 years in only 6 months) by replacing lab, in-vitro, in-vivo experience with in-sillico validation.

3
Animal Modeling

With our Bio-imaging approach, we do not have to kill the Animal Model to see the impact of a drug. Thus we are able to follow the evolution of the disease, see the impact of a molecule and better predict the efficacy in human.

Executive Board

A team profile essential for ABAXYS' mission, combining a long experience and strong know-how in Obesity and Neurosciences Drug Discovery, R&D, company creation and financing.

Our Team

  • /
    Javier Garcia Ladona
    Founder & CEO - Javier has 27+ years Experience and Leadership in R&D in Top Leading Pharma Companies
  • /
    Guillaume de Viron
    Investor - Guillaume is a finance and operations leader with 15 years in biotech and medtech
  • /
    Danielle Houart
    Investor - Strong investment experience in biotechnology and medical neurorehabilitation devices investments
  • /

Strengthen and Leading ABAXYS to Successful Treatments of Severe Human Diseases

Financial Advisory Board

Board's mission is to bring our Obesity Lead Programs into the Clinical Phases of Development.

The key objective is the consolidation of an investment round allowing ABAXYS’ growth, successful clinical entry and empowerment via a pharma partnership deal.

Our Team

  • /
    A. Baladi
    Business Executive & Finance leader 20+ years experience in pharma industry Former Vice-President Europe and Central Asia at PFIZER
  • /
    F. Driessens
    Founding & Managing Partner at Hualto 15+ years as CFO in SMEs Former ExCom member of Public Investment Fund
  • /
    V. Rutten
    Managing Partner at Hualto Former Director Enerwood Strong leadership experience in supporting corporate strategic transformation
  • /

For Investments or Partnership Interests contact us at:

FinancialAdvisoryBoard@Abaxysth.com

Or use the template

CONTACT

For investment and partnership interest, don't hesitate to contact us:

FinancialAdvisoryBoard@Abaxysth.com

The key objective is the consolidation of an investment round allowing ABAXY’s growth, successful clinical entry and empowerment via a pharma partnership deal.

Our Partners

Financial Advisory Board

YOU?